PS

Paul Sekhri

Chairman, President and CEO, vTv Therapeutics, Inc.

New York, New York

Investor
VC

Invests in

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Venture Capital
Pharmaceuticals
Biotechnology
Business Development
Licensing
Pharmaceutical Industry
Technology Transfer
Sop
Biomarkers
Lifesciences
Clinical Trials
Corporate Development
Medical Devices
Clinical Development
Product Launch
Neurology
Market Access
Strategic Planning
Oncology
Validation

Education

Lists including Paul

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

Investments

PatientSafe Solutions

Series C

Total Funding: $52M

moksha8 Pharmaceuticals

Series A

Total Funding: $39M

Work Experience

vT
vTv Therapeutics LLC

2022

  • Chair, President and CEO, vTv Therapeutics, Inc.

    2022

RT
Resolution Therapeutics

2024

  • Chair of the Board of Directors

    2024

K
Kayothera

2024

  • Member Board of Directors

    2024

A
AdhereTech

2024

  • Board Member

    2024

CL
Compugen Ltd.

2017

  • Chair of the Board of Directors

    2017

VS
Veeva Systems

2014

  • Board Member

    2014

OT
ORYN THERAPEUTICS, LLC

2022 - 2024

  • Board Member

    2022 - 2024

LP
Longboard Pharmaceuticals

2021 - 2024

  • Chair of the Board of Directors

    2021 - 2024

SD
Spring Discovery

2021 - 2024

  • Board Member

    2021 - 2024

eI
eGenesis, Inc.

2019 - 2024

  • Board Member

    2019 - 2024

  • President and CEO

    2019 - 2022

    eGenesis is revolutionizing the field of xenotransplantation.